BFC Planning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BFC Planning's BMY Position: Q3 2026 in Review
BFC Planning reduced its Bristol-Myers Squibb (BMY) stake by 4.7% in Q3 2026, selling an estimated $88.4K and leaving 28,604 shares worth $1.78M. The position accounts for 0.07% of the portfolio, ranked #266.
BFC Planning first reported a position in BMY in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.91M in Q1 2026. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- BFC Planning held 28,604 shares of Bristol-Myers Squibb worth $1.78M as of Q3 2026.
- BFC Planning sold 1,398 Bristol-Myers Squibb shares in Q3 2026, an estimated $88.4K.
- Bristol-Myers Squibb made up 0.07% of BFC Planning's portfolio in Q3 2026, its #266 holding.
- BFC Planning first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Bristol-Myers Squibb position peaked at $1.91M in Q1 2026.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.